Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE IN EUROPE
Dr Nodari said: “In the last few decades there has been a worrying increase in air pollution. Regardless of local environmental and social policies to approve air quality, the negative effect of air pollution continues to be an important public health problem.”
She added: “Some studies conducted in Europe and the US have reported an association between air pollution, especially fine and ultrafine particles which are measured as particulate matter (PM) 10, and not only respiratory disease but also acute cardiovascular events and deaths. The European Union has set a PM10 safety threshold of 50 micrograms/m3 but the negative effect of PM10 on the cardiovascular system may occur at levels lower than this cut off.”(1)
The current study set out to confirm the association between levels of PM10, which is a marker of general air pollution, and the risk of acute cardiovascular events. It also examined individual susceptibility to cardiovascular events during high PM10 levels. Data was collected on daily hospitalisations for cardiac events (acute coronary syndrome, acute heart failure, malignant ventricular arrhythmias and atrial fibrillation) and average daily concentrations of PM10 in Brescia during 2004 to 2007.The study found a significant association between PM10 levels and admission for acute cardiovascular events such as acute coronary syndromes, heart failure, worsening heart failure, paroxysmal atrial fibrillation and ventricular arrhythmias. The effect was linear, with a 3% increase in admissions for every 10 microgram increase in PM10.
Dr Nodari said: “Brescia is one of the most industrialised areas in the North of Italy and according to the European Environmental Agency it has average daily PM10 levels higher than the safety threshold of 50 micrograms/m3. This high level of air pollution is clearly having a bad effect on heart health.”
She added: “Previous studies support the hypothesis that air pollution may increase cardiovascular event rates because PM10 can induce processes that are bad for the heart including inflammation and coagulation.”
She concluded: “The current PM10 threshold of 50 micrograms/m3 is too high because at this level we observed an increase in hospitalisations for heart diseases. The cut off should be reduced to 20 - 30 micrograms/m3, or even less if possible, because like cholesterol the risk is continuous – the higher the levels the greater the risk. If we can obtain a lower level of PM10 probably we will lower the risk of heart disease.”